FDA Logo links to FDA home page Skip Navigation
U.S. Food and Drug Administration
 HHS Logo links to Department of Health and Human Services website
Skip navigationFDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions
horizonal rule
Dockets Management

Up | AC Home Page

Food and Drug Administration

Joint meeting of the

Cardiovascular and Renal Drugs Advisory Committee and the Drug Safety and Risk Management Committee

  September 11, 2007

BRIEFING INFORMATION

 

  FDA

Disclaimer

 

Portions of this document have been determined to be exempt from disclosure under the Freedom of Information Act (the FOIA) (5 U.S.C. § 552).

FDA Briefing Material (pdf)

Errata (pdf)

Bibliography (pdf) 

 

Amgen, Inc

 

Disclaimer

 

The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.

 

“Safety and Efficacy of Erythropoiesis-Stimulating Agents (ESAs) In Chronic Renal Failure“, Amgen, Inc

Briefing Material (pdf)

Page last updated September 7, 2007 kkhorizonal rule
Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA/Dockets Management